Evidence map›Paper›PMID 28796828›Full record

ArticlePloS one2017

Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples.

Gianni Bussolati, Laura Annaratone, Enrico Berrino, Umberto Miglio, Mara Panero, Marco Cupo, Patrizia Gugliotta, Tiziana Venesio, Anna Sapino, Caterina Marchiò

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Safe transportation of formalin-fixed liquid-free pathology specimens.Virchows Archiv : an international journal of pathology · 2018
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Gianni BussolatiDepartment of Medical Sciences, University of Turin, Turin, Italy.
Laura AnnaratoneDepartment of Medical Sciences, University of Turin, Turin, Italy.
Enrico BerrinoCandiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO), IRCCS, Candiolo, Italy.
Umberto MiglioCandiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO), IRCCS, Candiolo, Italy.
Mara PaneroCandiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO), IRCCS, Candiolo, Italy.
Marco CupoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Patrizia GugliottaDepartment of Medical Sciences, University of Turin, Turin, Italy.
Tiziana VenesioCandiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO), IRCCS, Candiolo, Italy.
Anna SapinoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Caterina MarchiòDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0003-2024-6131
Candiolo Cancer Institute · ITUniversity of Turin · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue fixation in phosphate buffered formalin (PBF) remains the standard procedure in histopathology, since it results in an optimal structural, antigenic and molecular preservation that justifies the pivotal role presently played by diagnoses on PBF-fixed tissues in precision medicine. However, toxicity of formaldehyde causes an environmental concern and may demand substitution of this reagent. Having observed that the reported drawbacks of commercially available glyoxal substitutes of PBF (Prefer, Glyo-fix, Histo-Fix, Histo-CHOICE, and Safe-Fix II) are likely related to their acidity, we have devised a neutral fixative, obtained by removing acids from the dialdehyde glyoxal with an ion-exchange resin. The resulting glyoxal acid-free (GAF) fixative has been tested in a cohort of 30 specimens including colon (N = 25) and stomach (N = 5) cancers. Our results show that GAF fixation produces a tissue and cellular preservation similar to that produced by PBF. Comparable immuno-histochemical and molecular (DNA and RNA) analytical data were obtained. We observed a significant enrichment of longer DNA fragment size in GAF-fixed compared to PBF-fixed samples. Adoption of GAF as a non-toxic histological fixative of choice would require a process of validation, but the present data suggest that it represents a reliable candidate.

Indexed as

DNAFixativesFormaldehydeGlyoxalHumansImmunohistochemistryIn Situ Hybridization, FluorescenceRNASequence Analysis, DNATissue FixationDNAFixativesFormaldehydeGlyoxalRNA

Identifiers

PMID28796828
PMCPMC5552132
OpenAlexW2742220911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.